CN101431959A - 钙吸收促进剂 - Google Patents

钙吸收促进剂 Download PDF

Info

Publication number
CN101431959A
CN101431959A CNA200780013329XA CN200780013329A CN101431959A CN 101431959 A CN101431959 A CN 101431959A CN A200780013329X A CNA200780013329X A CN A200780013329XA CN 200780013329 A CN200780013329 A CN 200780013329A CN 101431959 A CN101431959 A CN 101431959A
Authority
CN
China
Prior art keywords
calcium
medicament
preparation
treatment
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200780013329XA
Other languages
English (en)
Chinese (zh)
Inventor
松田秀秋
岩城正宏
川濑笃史
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridis Pharmaceutical Ltd
Original Assignee
Veritron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritron Ltd filed Critical Veritron Ltd
Publication of CN101431959A publication Critical patent/CN101431959A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
CNA200780013329XA 2006-02-17 2007-02-13 钙吸收促进剂 Pending CN101431959A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77437406P 2006-02-17 2006-02-17
US60/774,374 2006-02-17
JP041158/2006 2006-02-17
JP2006041158 2006-02-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2012102187846A Division CN102755374A (zh) 2006-02-17 2007-02-13 钙吸收促进剂

Publications (1)

Publication Number Publication Date
CN101431959A true CN101431959A (zh) 2009-05-13

Family

ID=38042502

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA200780013329XA Pending CN101431959A (zh) 2006-02-17 2007-02-13 钙吸收促进剂
CN2012102187846A Pending CN102755374A (zh) 2006-02-17 2007-02-13 钙吸收促进剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2012102187846A Pending CN102755374A (zh) 2006-02-17 2007-02-13 钙吸收促进剂

Country Status (15)

Country Link
US (2) US20090098222A1 (https=)
EP (2) EP1986566B1 (https=)
JP (1) JP5281895B2 (https=)
KR (1) KR20080103528A (https=)
CN (2) CN101431959A (https=)
AR (1) AR059577A1 (https=)
AT (1) ATE535283T1 (https=)
AU (1) AU2007215753B2 (https=)
BR (1) BRPI0708061A2 (https=)
CA (1) CA2642248A1 (https=)
MY (1) MY147271A (https=)
RU (1) RU2428193C2 (https=)
SG (1) SG169979A1 (https=)
TW (1) TW200800292A (https=)
WO (1) WO2007094486A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107929313A (zh) * 2017-11-21 2018-04-20 上海金城药业有限公司 用于预防和治疗钙缺乏症的天然型牡蛎碳酸钙制剂及其制备方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007039310A1 (de) * 2007-08-13 2009-02-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose
WO2010008786A2 (en) * 2008-06-23 2010-01-21 Amano Enzyme Usa, Ltd. Enzymatic methods of flavor modification
EP2836083B1 (en) 2012-04-10 2016-08-03 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Wet granulation process and granulate material comprising arabic gum
IT201900023016A1 (it) * 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
US20250228900A1 (en) * 2024-01-11 2025-07-17 Bios-Therapy, Physiological Systems For Health S.P.A. Natural matrix mixture for the treatment of bone fragility

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097601A (en) * 1977-08-26 1978-06-27 Pfizer Inc. Bone deposition by 2-descarboxy-2-(tetrazol-5-yl)-11-dexosy-16-aryl prostaglandins
US5545414A (en) * 1995-03-22 1996-08-13 Abbott Laboratories Cholesterol lowering food product
WO1996031130A2 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
JP4493736B2 (ja) 1995-09-01 2010-06-30 日本水産株式会社 キチンを含有するミネラル吸収促進性組成物およびミネラル吸収促進用添加剤
US5855936A (en) * 1997-03-21 1999-01-05 Nestec S.A. Food fortification
CN1090006C (zh) * 1997-03-24 2002-09-04 丸尾钙株式会社 食品添加剂料浆组合物和粉末组合物以及含该添加剂的食品组合物
JPH11313634A (ja) * 1998-03-12 1999-11-16 Internatl Flavors & Fragrances Inc <Iff> 呈味剤とその製造方法
EP0960572A1 (en) * 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
JP2000026283A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した粉末組成物
US6455082B1 (en) * 1999-04-26 2002-09-24 Nestec S.A. Shelf-stable calcium fortified milk and dairy products
JP2001186863A (ja) * 2000-01-05 2001-07-10 Maruo Calcium Co Ltd 食品添加剤スラリー組成物及びパウダー組成物、及びこれを含有する食品組成物
JP3563343B2 (ja) 2000-11-10 2004-09-08 株式会社東洋新薬 カルシウム利用効率が向上した食物繊維含有食品
JP2002223737A (ja) * 2001-02-02 2002-08-13 Dai Ichi Kogyo Seiyaku Co Ltd カルシウム強化飲料用分散剤、及びカルシウム含有粉末
JP4390428B2 (ja) * 2001-05-01 2009-12-24 株式会社林原生物化学研究所 含カルシウム組織強化剤
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US7138151B2 (en) * 2002-11-22 2006-11-21 Unilab Pharmatech, Ltd. Calcium-fortified acidic beverages
JP2004292382A (ja) * 2003-03-27 2004-10-21 Kirin Brewery Co Ltd ミネラル吸収促進剤及び骨粗鬆症用予防及び／又は改善剤
JP2005047820A (ja) * 2003-07-29 2005-02-24 Taiyo Kagaku Co Ltd 整腸用組成物
KR20030078050A (ko) * 2003-09-01 2003-10-04 주식회사 엠에스씨 고분산성 유청칼슘 조성물 및 그 제조방법
CN1833727B (zh) * 2005-03-18 2010-07-28 潘思源 阿拉伯树胶在建立动物模型和降低血胆固醇中的用途
US20070003671A1 (en) * 2005-07-01 2007-01-04 Anglea Timothy A Two-part calcium fortified compositions and methods of making the same
CN101484146A (zh) * 2006-05-23 2009-07-15 奥拉黑尔斯公司 木糖醇锭剂及其用法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107929313A (zh) * 2017-11-21 2018-04-20 上海金城药业有限公司 用于预防和治疗钙缺乏症的天然型牡蛎碳酸钙制剂及其制备方法
CN107929313B (zh) * 2017-11-21 2021-02-19 上海金城素智药业有限公司 用于预防和治疗钙缺乏症的天然型牡蛎碳酸钙制剂及其制备方法

Also Published As

Publication number Publication date
US20090098222A1 (en) 2009-04-16
CN102755374A (zh) 2012-10-31
ATE535283T1 (de) 2011-12-15
US20110045014A1 (en) 2011-02-24
SG169979A1 (en) 2011-04-29
MY147271A (en) 2012-11-30
JP5281895B2 (ja) 2013-09-04
JP2009526748A (ja) 2009-07-23
AU2007215753B2 (en) 2013-04-18
AU2007215753A1 (en) 2007-08-23
RU2008137129A (ru) 2010-03-27
EP2298276A1 (en) 2011-03-23
TW200800292A (en) 2008-01-01
WO2007094486A1 (en) 2007-08-23
AR059577A1 (es) 2008-04-16
CA2642248A1 (en) 2007-08-23
RU2428193C2 (ru) 2011-09-10
KR20080103528A (ko) 2008-11-27
EP1986566B1 (en) 2011-11-30
BRPI0708061A2 (pt) 2011-05-17
EP2298276B1 (en) 2020-01-15
EP1986566A1 (en) 2008-11-05

Similar Documents

Publication Publication Date Title
CN1649644A (zh) 用奶矿物质和酪蛋白组分治疗体重异常的组合物和方法
AU2006227949B2 (en) Composition and method for modulating hydrogen ion physiology
KR20060052818A (ko) 미네랄 흡수 촉진제 및 그 용도
TW200848064A (en) Process for producing osteocalcin-containing extract
AU2007236638A1 (en) Fat accumulation inhibitor
JP3381010B2 (ja) プロポリスエキスを含有する発酵物とその製造方法並びに用途
CN101415429B (zh) 脂肪蓄积抑制剂
US20110045014A1 (en) Acceleration agent of calcium absorption
JP3393560B2 (ja) 水溶性キトサンを含有するカルシウム吸収促進性組成物およびカルシウム吸収促進用添加剤
EP2127663A1 (en) Adiponectin production enhancer
WO2004084919A1 (ja) 血中低分子量含窒素化合物の濃度を低減させる病態改善用食品
JP2001269135A (ja) 体タンパク質蓄積効率を亢進する栄養組成物
JP4914594B2 (ja) 関節痛改善用食品組成物
JP2007022989A (ja) 抗疲労剤
JPH09132531A (ja) 流動食添加用組成物及び流動食
JP2964290B2 (ja) ミネラル吸収促進剤
ES2781428T3 (es) Agente acelerador de absorción de calcio
JP2010095474A (ja) カルシウム吸収促進組成物及びカルシウム吸収促進飲食物
JP4085118B2 (ja) カルシウム吸収促進作用を有する食酢飲料およびその製造方法
JP2013224277A (ja) 経口骨強化組成物及びそれを含有する飲食品、医薬又は飼料
TW201825011A (zh) 蛋白質效率提升用之組成物
JPH1066515A (ja) 脂質代謝改善剤及びそれを用いた食品
JP2000212079A (ja) ミネラル吸収促進剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: CUILV DRUG CO., LTD.

Free format text: FORMER OWNER: FLEETLONG CO., LTD.

Effective date: 20100520

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: LONDON, UNITED KINGDOM TO: BRITISH VIRGIN ISLANDS

TA01 Transfer of patent application right

Effective date of registration: 20100520

Address after: Virgin Islands (British)

Applicant after: Viridis Pharmaceutical Ltd.

Address before: London, England

Applicant before: Veritron Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090513